Self-amplifying mRNA COVID-19 vaccine 'immunogenicity enhancer’ enters Phase 1 trial

Self-amplifying mRNA COVID-19 vaccine 'immunogenicity enhancer’ enters Phase 1 trial

Submitted by admin on September 20, 2021 - 11:50am
Source: 
Biopharma Reporter
News Tags: 
Gritstone Bio
clinical trials
vaccines
COVID-19
MRNA
immunogenicity enhancer
Headline: 
Self-amplifying mRNA COVID-19 vaccine 'immunogenicity enhancer’ enters Phase 1 trial
snippet: 

Gritstone bio, Inc., has dosed the first volunteer in a Phase 1 trial for a self-amplifying mRNA second-generation COVID-19 vaccine booster.

Do Not Allow Advertisers to Use My Personal information